comprehensive -WSS

comprehensive

author：focus 2025-10-01 07:41:39 - browse：292

When is a failure not a failure? Does the FDA have special rules for Sarepta Therapeutics? And how do you say “brash” in French?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Biotech consultant Frank David joins us to explain the wild world of subgroup analyses and how to discern science from spin. We also discuss the latest news in the life sciences, including the future of Sarepta and the retirement of a biotech stalwart.

For more on what we cover, here’s where you can read Frank’s work; here’s more on Sarepta; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： My yearlong odyssey to get my son’s ADHD medication covered

WSS

EU regulator recommends expanding Mounjaro approval to obesity

FDA clears AI tool for detecting skin cancer

Hey, doctors: Don't be no

Grand jury probing Trump's efforts to overturn 2020 election did not meet Friday: Sources

The surgeon had a dilemma only a Nazi medical text could resolve

Trump Organization, Michael Cohen agree to settle million

hotspot

comprehensive

focus

Affirmative action in medical school literally saved lives

Francis Collins on trust in science and how Covid communications failed

Peter Hotez and the public health issue of online harassment

Dispute over threat of extinction posed by artificial intelligence looms over surging industry

What does generative AI mean for health care? We asked experts

Reframing the conversation around gain

Hepatitis C has a cure — but many Americans still lack access to it

Biotech venture capitalists face new demands from investors

Duchenne breakthrough therapy leaves behind pioneering families

The biotech scorecard for the 2nd quarter: 12 industry events to watch

knowledge

The biotech scorecard for the 2nd quarter: 12 industry events to watch

Study: Misdiagnosis causes 800,000 deaths, serious disabilities a year in U.S.

Humana cuts profit projections as Medicare Advantage costs soar

EU regulator recommends expanding Mounjaro approval to obesity

Gilead’s Trodelvy fails in lung cancer, raises questions on ADCs

Language on climate change, ESG removed from company website of Montana GOP Senate candidate

focus

Wikipedia

focus

Wikipedia